View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports

Posbank Co Ltd: 1 director

A director at Posbank Co Ltd bought 496,574 shares at 5,006.000KRW and the significance rating of the trade was 76/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cl...

 PRESS RELEASE

VERB’s Healthy Balance and Enhanced Shareholder Equity Behind Nasdaq’s...

VERB’s Healthy Balance and Enhanced Shareholder Equity Behind Nasdaq’s Grant of 6-Month Extension to Regain Compliance With Bid Price Rule Fully-Funded Business Plan, Excess Cash On Balance Sheet, Debt Slashed, No Going Concern Opinion, Under-Performing Assets Sold And Restructuring Complete, VERB’s MARKET.live Business Positioned For Success LOS ALAMITOS, Calif. and LAS VEGAS, May 02, 2024 (GLOBE NEWSWIRE) -- Verb Technology Company, Inc. (Nasdaq: VERB) ("VERB" or the "Company"), the force behind MARKET.live, the popular livestream social shopping platform, today announces that Nasdaq ...

 PRESS RELEASE

Blink Charging Selected as Official Electric Vehicle Charger and Netwo...

Blink Charging Selected as Official Electric Vehicle Charger and Network Services Provider for State of New York Blink to provide expanded charging infrastructure and support a more sustainable future for the state. Bowie, Md., May 02, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: BLNK) (“Blink” or the “Company”), a leading global manufacturer, owner, operator and provider of electric vehicle (EV) charging equipment and services, has announced it has secured a contract as an official EV charging provider for the state of New York. The agreement sets the stage for Blink Charging and New York to ...

 PRESS RELEASE

EQS-News: Rentschler Biopharma ernennt Patrick Cushing zum VP Operatio...

EQS-News: Rentschler Biopharma SE / Schlagwort(e): Personalie Rentschler Biopharma ernennt Patrick Cushing zum VP Operations am US-Standort im Raum Boston 02.05.2024 / 14:10 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Rentschler Biopharma ernennt Patrick Cushing zum VP Operations am US-Standort im Raum Boston   Laupheim, Milford (MA), USA, und Stevenage, UK, 2. Mai 2024 – Rentschler Biopharma SE, ein führendes Dienstleistungs- und Auftragsentwicklungsunternehmen (CDMO) für Biopharmazeutika, gab heute bekannt, dass Dr. Patrick Cu...

 PRESS RELEASE

EQS-News: Rentschler Biopharma Appoints Patrick Cushing as VP Operatio...

EQS-News: Rentschler Biopharma SE / Key word(s): Personnel Rentschler Biopharma Appoints Patrick Cushing as VP Operations for U.S. Subsidiary 02.05.2024 / 14:10 CET/CEST The issuer is solely responsible for the content of this announcement. Rentschler Biopharma Appoints Patrick Cushing as VP Operations for U.S. Subsidiary   Laupheim, Germany, Milford (MA), USA, and Stevenage, UK, May 2, 2024 – Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, today announced that Patrick Cushing, Ph.D., has been ...

 PRESS RELEASE

EQS-News: Northern Data Group's wegweisender Colocation-Anbieter, Arde...

EQS-News: Northern Data AG / Schlagwort(e): Sonstiges Northern Data Group's wegweisender Colocation-Anbieter, Ardent Data Centers, setzt den ersten Spatenstich für die Erweiterung des Rechenzentrums in Pittsburgh 02.05.2024 / 14:00 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. PRESSEMITTEILUNG / IR-NACHRICHT Northern Data Group's wegweisender Colocation-Anbieter, Ardent Data Centers, setzt den ersten Spatenstich für die Erweiterung des Rechenzentrums in Pittsburgh   Das Rechenzentrum in Pittsburgh beschleunigt den Ausbau des Coloca...

 PRESS RELEASE

EQS-News: Northern Data Group’s cutting-edge colocation provider, Arde...

EQS-News: Northern Data AG / Key word(s): Miscellaneous Northern Data Group’s cutting-edge colocation provider, Ardent Data Centers, breaks ground on upgrade to Pittsburgh data center 02.05.2024 / 14:00 CET/CEST The issuer is solely responsible for the content of this announcement. PRESS RELEASE / IR NEWS Northern Data Group’s cutting-edge colocation provider, Ardent Data Centers, breaks ground on upgrade to Pittsburgh data center   Pittsburgh data center will accelerate Ardent’s colocation offering in the United States 41,000 square foot building being upgraded with t...

XL Holdings Berhad: 1 director

A director at XL Holdings Berhad bought 4,200,000 shares at 0.687MYR and the significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years ...

Oluebube Nwosu
  • Oluebube Nwosu

LAFARGE AFRICA PLC Q1'24 Earnings Release - FX losses weaken bottom li...

For the first quarter, Lafarge recorded strong revenue growth of 50% y/y to ₦137.7 billion, driven by improved sales volumes, and higher cement prices. On the other hand, cost of sales increased by 59% y/y to ₦72.1 billion. Despite management’s efforts to rein in the cost pressures, cost of inputs such as fuel, power, and raw materials (+61% y/y: ₦45.5 billion) was exacerbated by the rising inflationary pressures and the continuous weakening of the currency. In light of this, gross margin ...

Oluebube Nwosu
  • Oluebube Nwosu

GUINNESS NIGERIA PLC 9M'24 Earnings Release - Macro headwinds drag per...

Topline expands on price increases.In Q3’24, Guinness Nigeria demonstrated robust revenue growth, despite the prevailing macro challenges. The company delivered a satisfactory topline performance, driven primarily by increased pricing amid a decline in sales volume. Revenue for the quarter surged 44% y/year to ₦77.7 billion, as a result of this higher pricing.However, the company’s margins came under pressure due to rising costs. The jump in cost of sales outpaced revenue growth, rising by...

 PRESS RELEASE

Longeveron to Report First Quarter 2024 Financial Results and Host Con...

Longeveron to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024 MIAMI, May 02, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: LGVN), a clinical stage biotechnology company developing regenerative medicines, today announced that it will report first quarter 2024 financial results and provide a business update on Tuesday, May 14, 2024 after the U.S. financial markets close. The Company will host a conference call and webcast the same day at 5:00 p.m. ET. Conference Call Details:    Conference Call Number:  1.877.407.0789    Conference ID:  13745868    Call meTM...

 PRESS RELEASE

EQS-News: CPI PROPERTY GROUP – Sale of Crans Montana Ski Resort

EQS-News: CPI PROPERTY GROUP / Key word(s): Real Estate CPI PROPERTY GROUP – Sale of Crans Montana Ski Resort 02.05.2024 / 13:56 CET/CEST The issuer is solely responsible for the content of this announcement. CPI Property Group (société anonyme) 40, rue de la Vallée L-2661 Luxembourg R.C.S. Luxembourg: B 102 254                                                                                                                             Press Release - Corporate News Luxembourg, 2 May 2024CPI PROPERTY GROUP – Sale of Crans Montana Ski Resort CPI PROPERTY GROUP (“CPIPG” or th...

 PRESS RELEASE

Mersana Therapeutics to Host First Quarter 2024 Conference Call on May...

Mersana Therapeutics to Host First Quarter 2024 Conference Call on May 9, 2024 CAMBRIDGE, Mass., May 02, 2024 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of high unmet medical need, today announced that it will provide business updates and report its financial results for the first quarter ended March 31, 2024 on Thursday, May 9, 2024. The company will host a conference call and webcast at 8:00 a.m. Eastern Time that m...

Edda Wind ASA: 3 directors

Three Directors at Edda Wind ASA sold/bought 32,316,131 shares at 24.500NOK. The significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two y...

IOI Properties Group Berhad: 1 director

A director at IOI Properties Group Berhad sold 47,530,000 shares at 2.052MYR and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last tw...

 PRESS RELEASE

Allarity Therapeutics’ Stenoparib Shows Clear Clinical Benefit and Ach...

Allarity Therapeutics’ Stenoparib Shows Clear Clinical Benefit and Achieves Significant Milestone with Early Conclusion of Phase 2 Trial in Advanced Ovarian Cancer Boston (May 2, 2024)—Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a clinical-stage pharmaceutical company dedicated to developing personalized cancer treatments, today announced the early discontinuation of its Phase 2 clinical trial of stenoparib, a novel PARP inhibitor, for the treatment of advanced recurrent ovarian cancer. The patients enrolled in the trial had been pre-screened by Allarity’s uniq...

 PRESS RELEASE

New York Jets Announce Multi-Year Partnership with VitaCholine®

New York Jets Announce Multi-Year Partnership with VitaCholine® First Professional Sports Partnership for VitaCholine® encompasses rights across regions including the United States and the United Kingdom. MONTVALE, N.J., May 02, 2024 (GLOBE NEWSWIRE) -- The New York Jets announced a partnership with VitaCholine, a Balchem Human Nutrition and Health brand of the essential nutrient choline, as Proud Partner of the team. This agreement marks VitaCholine’s first sponsorship and the first sponsorship in the Nutritional Ingredient category of a major professional sports team. The multi-year a...

 PRESS RELEASE

Bebuzee’s Revolutionary Super App Will Disrupt US and European Markets

Bebuzee’s Revolutionary Super App Will Disrupt US and European Markets With its comprehensive suite of features, the app caters to the ever-evolving needs of modern users, providing a one-stop digital demand solution. MIAMI, May 02, 2024 (GLOBE NEWSWIRE) -- via IBN – a social platform and streaming service focused on developing and deploying America's first Super App, today announces the launch of its game-changing Super App, set to redefine the digital landscape in the United States and Europe. This all-in-one app is a testament to Bebuzee's commitment to pushing the boundaries of t...

 PRESS RELEASE

Mineralys Therapeutics to Announce First Quarter 2024 Financial Result...

Mineralys Therapeutics to Announce First Quarter 2024 Financial Results and Host Conference Call on Thursday, May 9, 2024 RADNOR, Pa., May 02, 2024 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (NASDAQ: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic kidney disease (CKD) and other diseases driven by dysregulated aldosterone, today announced it will report its financial results from the first quarter ended March 31, 2024, before the financial markets open on Thursday, May 9, 2024. Thursday, May 9th @ 8:30 a.m. ETDomestic:...

 PRESS RELEASE

Amphenol Announces Second Quarter 2024 Dividend

WALLINGFORD, Conn.--(BUSINESS WIRE)-- Amphenol Corporation (NYSE: APH) announced today that its Board of Directors approved the second quarter 2024 dividend on its Common Stock in the amount of $0.22 per share at its meeting held on May 1, 2024. The Company will pay this second quarter 2024 dividend on July 10, 2024 to shareholders of record as of June 18, 2024. About Amphenol Amphenol Corporation is one of the world’s largest designers, manufacturers and marketers of electrical, electronic and fiber optic connectors and interconnect systems, antennas, sensors and sensor-based products and...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch